FDAnews Drug Daily Bulletin

Authorized Generic Deals May Be a Thing of the Past, Lawyer Says

Aug. 2, 2012
Drug companies’ patent settlements may no longer need clauses preventing authorized generic (AG) launches after last month’s landmark court decision on pay-for-delay deals, a pharma lawyer says. Reverse settlements with side deals and other payments now will be presumed to be anticompetitive, Steve Maddox, partner with Knobbe Martens, said July 18.
Generic Line